A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

Condition:   Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma Intervention:   Drug: Treatment with Poziotinib Sponsor:   Yonsei University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials